These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19138331)

  • 21. Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis.
    Klíčová K; Mareš J; Menšíková K; Kaiserová M; Friedecký D; Kaňovský P; Strnad M; Matěj R
    Eur J Med Res; 2024 Jan; 29(1):31. PubMed ID: 38184629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
    Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
    J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Nagata T; Nagano I; Shiote M; Narai H; Murakami T; Hayashi T; Shoji M; Abe K
    Neurol Res; 2007 Dec; 29(8):772-6. PubMed ID: 17672928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF levels in CSF and serum in mild ALS patients.
    Gao L; Zhou S; Cai H; Gong Z; Zang D
    J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan.
    Nishimura T; Takeda M; Nakamura Y; Yosbida Y; Arai H; Sasaki H; Shouji M; Hirai S; Khise K; Tanaka K; Hamamoto M; Yamamoto H; Matsubayashi T; Urakami K; Adachi Y; Nakashima K; Toji H; Nakamura S; Yoshida H
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):227-35. PubMed ID: 9646285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of cerebral spinal fluid pH and HCO3- with disease progression in ALS.
    Morimoto N; Deguchi K; Sato K; Yunoki T; Deguchi S; Ohta Y; Kurata T; Takao Y; Ikeda Y; Matsuura T; Abe K
    J Neurol Sci; 2011 Aug; 307(1-2):74-8. PubMed ID: 21632065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.
    Hosokawa M; Arai T; Yamashita M; Tsuji H; Nonaka T; Masuda-Suzukake M; Tamaoka A; Hasegawa M; Akiyama H
    Int J Neurosci; 2014 May; 124(5):344-9. PubMed ID: 24066851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.
    Martínez-Yélamos A; Saiz A; Bas J; Hernandez JJ; Graus F; Arbizu T
    Neurosci Lett; 2004 Jun; 363(1):14-7. PubMed ID: 15157986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients].
    Iłzecka J; Stelmasiak Z; Dobosz B
    Neurol Neurochir Pol; 2001; 35(6):1035-43. PubMed ID: 11987700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis.
    Roos PM; Vesterberg O; Syversen T; Flaten TP; Nordberg M
    Biol Trace Elem Res; 2013 Feb; 151(2):159-70. PubMed ID: 23225075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
    Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic value of tau in cerebrospinal fluid in alzheimer disease].
    Hu Y; He S; Wang J
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1377-9. PubMed ID: 11930632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.
    Kuhle J; Lindberg RL; Regeniter A; Mehling M; Steck AJ; Kappos L; Czaplinski A
    Eur J Neurol; 2009 Jun; 16(6):771-4. PubMed ID: 19236470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot trial of memantine and riluzole in ALS: correlation to CSF biomarkers.
    Levine TD; Bowser R; Hank N; Saperstein D
    Amyotroph Lateral Scler; 2010 Dec; 11(6):514-9. PubMed ID: 20839903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.